17,18-dihydroxyluotonin A

ID: ALA241771

Chembl Id: CHEMBL241771

PubChem CID: 136124356

Max Phase: Preclinical

Molecular Formula: C18H11N3O3

Molecular Weight: 317.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1c2cc(O)c(O)cc2nc2n1Cc1cc3ccccc3nc1-2

Standard InChI:  InChI=1S/C18H11N3O3/c22-14-6-11-13(7-15(14)23)20-17-16-10(8-21(17)18(11)24)5-9-3-1-2-4-12(9)19-16/h1-7,22-23H,8H2

Standard InChI Key:  RKNNJIBYRWYYOF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CEM/C2 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 317.30Molecular Weight (Monoisotopic): 317.0800AlogP: 2.38#Rotatable Bonds:
Polar Surface Area: 88.24Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.48CX Basic pKa: 2.65CX LogP: 2.54CX LogD: 2.28
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.43Np Likeness Score: 0.07

References

1. Nacro K, Zha CC, Guzzo PR, Jason Herr R, Peace D, Friedrich TD..  (2007)  Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.,  15  (12): [PMID:17418582] [10.1016/j.bmc.2007.03.067]

Source